Block Listing Update

RNS Number : 7123M
Futura Medical PLC
11 May 2015
 

For immediate release

11 May 2015

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Block Listing Update

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in November 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.

The table below provides further detail.

 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")

 

Period of return:

From:

11 November 2014

To:

11 May 2015

 

Number and class of securities not issued under the scheme(s)

USOS:

1,786,435

EMI:

1,828,306

Total:

3,614,741

 

 

Number of securities issued under the scheme(s) during the period

 

 

Number of securities lapsed under the scheme(s) during the period

USOS:

Nil

EMI:

 

 

USOS:

EMI:

Total:

Nil

 

 

345,835

434,165

780,000

 

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

 

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

Total:

2,016,704 Total



EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

Total:

2,988,296 Total




Total:

5,005,000

 

 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

 

 

For further information please contact:                          

 

Futura Medical plc                                                             


James Barder, Chief Executive                                           

+ 44 (0) 1483 685 670                                                         

james.barder@futuramedical.com                                      

www.futuramedical.com

 

 



N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Thomas Smale

+44 (0) 20 7496 3000




For media enquiries please contact:

 

Buchanan

Mark Court / Sophie Cowles / Stephanie Watson

+ 44 (0) 20 7466 5000


 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUPGAUPAGRU
UK 100

Latest directors dealings